SARS molecular epidemiology: A Chinese fairy tale of controlling an emerging zoonotic disease in the genomics era

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 362, Issue 1482, 2007, Pages 1063-1081

  Zhao, Guo Ping ^a  

^a CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

Author keywords

Epidemiology; Evolution; Genomics; SARS coronavirus; Severe acute respiratory syndrome; Zoonotic disease

Indexed keywords

DISEASE; ETIOLOGY; GENOMICS; PUBLIC HEALTH; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS;

ASIA; CHINA; EURASIA; FAR EAST; GUANGDONG;

ANIMALIA; CORONAVIRUS; RHINOLOPHUS; SARS CORONAVIRUS;

ANIMAL; CHINA; DISEASE TRANSMISSION; GENETICS; GENOMICS; HUMAN; PATHOGENICITY; PATHOLOGY; REVIEW; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIROLOGY; ZOONOSIS;

ANIMALS; CHINA; GENOMICS; HUMANS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; ZOONOSES;

EID: 34347396620     PISSN: 09628436     EISSN: None     Source Type: Journal    
DOI: 10.1098/rstb.2007.2034     Document Type: Review

References (110)

1. Abubakar, S., Chang, L. Y., Ali, A. R., Sharifah, S. H., Yusoff, K. & Zamrod, Z. 2004 Isolation and molecular identification of Nipah virus from pigs. Emerg. Infect. Dis. 10, 2228-2230.
2. Anderson, R. M., Fraser, C., Ghani, A. C., Donnelly, C. A., Riley, S., Ferguson, N. M., Leung, G. M., Lam, T. H. & Hedley, A. J. 2004 Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic. Phil. Trans. R. Soc. B 359, 1091-1105. (doi:10.1098/rstb.2004.1490)
3. Babcock, G. J., Esshaki, D. J., Thomas Jr, W. D. & Ambrosino, D. M. 2004 Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor. J. Virol. 78, 4552-4560. (doi:10.1128/JVI.78.9.4552-4560.2004)
4. Bartlam, M., Yang, H. & Rao, Z. 2005 Structural insights into SARS coronavirus proteins. Curr. Opin. Struct. Biol. 15, 664-672. (doi:10.1016/j.sbi.2005.10.004)
5. Bernini, A. et al. 2004 Prediction of quaternary assembly of SARS coronavirus peplomer. Biochem. Biophys. Res. Commun. 325, 1210-1214. (doi:10.1016/j.bbrc.2004. 10.156)
6. Bi, S. et al. 2003 Complete genome sequences of the SARS-CoV: the BJ Group (Isolates BJ01-BJ04). Genomics Proteomics Bioinformatics 1, 180-192.
7. Bukreyev, A., Lamirande, E. W., Buchholz, U. J., Vogel, L. N., Elkins, W. R., St Claire, M., Murphy, B. R., Subbarao, K. & Collins, P. L. 2004 Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet 363, 2122-2127. (doi:10.1016/S0140-6736(04)16501-X)
8. CDCP 2003 Update: outbreak of severe acute respiratory syndrome-worldwide. MMWR Morb. Mortal. Wkly Rep. 52, 269-272.
9. Chan, K. H. et al. 2004a Detection of SARS coronavirus in patients with suspected SARS. Emerg. Infect. Dis. 10, 294-299.
10. Chan, P. K. et al. 2004b Laboratory diagnosis of SARS. Emerg. Infect. Dis. 10, 825-831.
11. Che, X. Y. et al. 2004 Nucleocapsid protein as early diagnostic marker for SARS. Emerg. Infect. Dis. 10, 1947-1949.
12. Cheng, P. K., Wong, D. A., Tong, L. K., Ip, S. M., Lo, A. C., Lau, C. S., Yeung, E. Y. & Lim, W. W. 2004 Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. Lancet 363, 1699-1700. (doi:10.1016/S0140-6736(04)16255-7)
13. Chinese, S. M. E. C. 2004 Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 303, 1666-1669. (doi:10.1126/science. 1092002)
14. Chiu, R. W., Chim, S. S., Tong, Y. K., Fung, K. S., Chan, P. K., Zhao, G. P. & Lo, Y. M. 2005 Tracing SARS-coronavirus variant with large genomic deletion. Emerg. Infect. Dis. 11, 168-170.
15. Christian, M. D., Poutanen, S. M., Loutfy, M. R., Muller, M. P. & Low, D. E. 2004 Severe acute respiratory syndrome. Clin. Infect. Dis. 38, 1420-1427. (doi:10. 1086/420743)
16. Chua, K. B. et al. 2000 Nipah virus: a recently emergent deadly paramyxovirus. Science 288, 1432-1435. (doi:10. 1126/science.288.5470.1432)
17. Davidson, A. & Siddell, S. 2003 Potential for antiviral treatment of severe acute respiratory syndrome. Curr. Opin. Infect. Dis. 16, 565-571. (doi:10.1097/00001432-200312000-00009)
18. Ding, Y. et al. 2003a The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J. Pathol. 200, 282-289. (doi:10.1002/path.1440)
19. Ding, Y. Q. et al. 2003b Study on etiology and pathology of severe acute respiratory syndrome. Zhonghua Bing Li Xue Za Zhi 32, 195-200.
20. Drosten, C. et al. 2003a Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl J. Med. 348, 1967-1976. (doi:10.1056/NEJMoa 030747)
21. Drosten, C., Preiser, W., Gunther, S., Schmitz, H. & Doerr, H. W. 2003b Severe acute respiratory syndrome: identification of the etiological agent. Trends Mol. Med. 9, 325-327. (doi:10.1016/S1471-4914(03)00133-3)
22. Drosten, C. et al. 2004 Evaluation of advanced reverse transcription-PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus. J. Clin. Microbiol. 42, 2043-2047. (doi:10.1128/JCM.42.5.2043-2047.2004)
23. Duan, J.-H., Wu, J., Lin, L.-F., Pei, F.-Q., Yi, J.-R., Lu, W.-C. & Cai, S.-W. 2003 Preliminary report on SARS coronavirus detection from vector rat and cockroach by RT-PCR. Chin. J. Vector Biol. Control 14, 332-334.
24. Enserink, M. 2003 SARS in China. China's missed chance. Science 301, 294-296. (doi:10.1126/science.301.5631.294)
25. Enserink, M. 2004 One year after outbreak. SARS virus yields some secrets. Science 304, 1097. (doi:10.1126/ science.304.5674.1097)
26. Fang, Y., Xu, Y., Dai, J.-Y., Peng, G.-W. & Yu, D.-W. 2003 The establishment of an epidemic reporting system for the infectious atypical pneumonia of Guangdong Province. South China J. Prev. Med. 29, 57-58.
27. Guan, Y. et al. 2003 Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302, 276-278. (doi:10.1126/science. 1087139)
28. Han, D. P., Kim, H. G., Kim, Y. B., Poon, L. L. & Cho, M. W. 2004 Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein. Virology 326, 140-149. (doi:10.1016/j.virol.2004. 05.017)
29. Hao, P., Chen, M., Zhang, G., He, W. & Li, Y. 2006 Bioinformatics research on the SARS coronavirus in China. Curr. Pharm. Des. 12, 4565-4572.
30. Harcourt, B. H. et al. 2005 Genetic characterization of Nipah virus, Bangladesh. Emerg. Infect. Dis. 11, 1594-1597.
31. He, J. F., Peng, G. W., Zheng, H. Z., Luo, H. M., Liang, W. J., Li, L. H., Guo, R. N. & Deng, Z. H. 2003a An epidemiological study on the index cases of severe acute respiratory syndrome occurring in different cities among Guangdong province. Zhonghua Liu Xing Bing Xue Za Zhi 24, 347-349.
32. He, J. F. et al. 2003b Severe acute respiratory syndrome in Guangdong Province of China: epidemiology and control measures. Zhonghua Yu Fang Yi Xue Za Zhi 37, 227-232.
33. Hofmann, H., Geier, M., Marzi, A., Krumbiegel, M., Peipp, M., Fey, G. H., Gramberg, T. & Pohlmann, S. 2004 Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor. Biochem. Biophys. Res. Commun. 319, 1216-1221. (doi:10.1016/j.bbrc.2004.05.114)
34. Holmes, K. V. 2003 SARS coronavirus: a new challenge for prevention and therapy. J. Clin. Invest. 111, 1605-1609. (doi:10.1172/ JCI200318819)
35. Hon, K. L. et al. 2003 Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet 361, 1701-1703. (doi:10.1016/S0140-6736(03)13364-8)
36. Hudson, P. J., Rizzoli, A. & Bryan, G. (eds) 2002 The ecology of wildlife diseases. Oxford, UK: Oxford University Press.
37. Hui, D. S., Wong, P. C. & Wang, C. 2003 SARS: clinical features and diagnosis. Respirology 8(Suppl), S20-S24. (doi:10.1046/j.1440- 1843.2003.00520.x)
38. Kaiser, L., Briones, M. S. & Hayden, F. G. 1999 Performance of virus isolation and Directigen Flu A to detect influenza A virus in experimental human infection. J. Clin. Virol. 14, 191-197. (doi:10.1016/S1386- 6532(99)00058-X)
39. Khamsi, R. 2004 Simple SARS detection. Nature 432, 163. (doi:10.1038/432163a)
40. Ksiazek, T. G. et al. 2003 A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1953-1966. (doi:10.1056/NEJMoa030781)
41. Kuiken, T. et al. 2003 Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362, 263-270. (doi:10.1016/S0140-6736(03) 13967-0)
42. Lau, S. K. et al. 2004 Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in SARS patients by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 42, 2884-2889. (doi:10.1128/JCM.42. 7.2884-2889.2004)
43. Lau, S. K. et al. 2005 Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc. Natl Acad. Sci. USA 102, 14 040-14 045. (doi:10.1073/ pnas.0506735102)
44. Lee, N. et al. 2003 A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348, 1986-1994. (doi:10.1056/NEJMoa030685)
45. Leung, C. W. et al. 2004a Severe acute respiratory syndrome among children. Pediatrics 113, e535-e543. (doi:10.1542/ peds.H3.6.e535)
46. Leung, G. M. et al. 20046 SARS-CoV antibody prevalence in all Hong Kong patient contacts. Emerg. Infect. Dis. 10, 1653-1656.
47. Li, L., Wo, J., Shao, J., Zhu, H., Wu, N., Li, M., Yao, H., Hu, M. & Dennin, R. H. 2003a SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients. J. Clin. Virol. 28, 239-244. (doi:10.1016/ S1386-6532(03)00195-1)
48. Li, W. et al. 2003b Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450-454. (doi:10.1038/nature02145)
49. Li, T. et al. 2004a Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome. J. Infect. Dis. 189, 648-651. (doi:10.1086/381535)
50. Li, W., Greenhough, T. C., Moore, M. J., Vasilieva, N., Somasundaran, M., Sullivan, J. L., Farzan, M. & Hyeryun, C. 2004b Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2. J. Virol. 78, 11429-11433. (doi:10.1128/JVI.78.20.11429-11433. 2004)
51. Li, F., Li, W., Farzan, M. & Harrison, S. C. 2005a Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309, 1864-1868. (doi:10.1126/science.1116480)
52. Li, W. et al. 2005b Bats are natural reservoirs of SARS-like coronaviruses. Science 310, 676-679. (doi:10.1126/science. 1118391)
53. Li, W. et al. 2005c Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J. 24, 1634-1643. (doi:10.1038/sj.emboj.7600640)
54. Lipsitch, M. et al. 2003 Transmission dynamics and control of severe acute respiratory syndrome. Science 300, 1966-1970. (doi:10.1126/science.1086616)
55. Liu, Z.-H., Huang, R., Lin, H.-Z., Zhang, P.-H. & Liu, X.-M. 2003 Investigation and analysis of coronaviruses carried by rodents. Chin. J. Epidemiol. 24, 1140.
56. Liu, Z.-H., Cheng, S.-J., Guo, Z.-M., Qu, L.-Z., Wei, S.-L., Gu, W.-W. & Huang, R. 2004 Investigation of source of SARS virus in laboratory animals and zoo animals. ACTA Laboratorium Animals Scientia Sinica 12, 50-52.
57. Marra, M. A. et al. 2003 The genome sequence of the SARS-associated coronavirus. Science 300, 1399-1404. (doi:10.1126/science.1085953)
58. Martina, B. E., Haagmans, B. L., Kuiken, T., Fouchier, R. A., Rimmelzwaan, G. F., Van Amerongen, G., Peiris, J. S., Lim, W. & Osterhaus, A. D. 2003 Virology: SARS virus infection of cats and ferrets. Nature 425, 915. (doi:10.1038/425915a)
59. Murray, K. et al. 1995 A morbillivirus that caused fatal disease in horses andhumans. Science 268, 94-97. (doi:10. 1126/science.7701348)
60. Ng, E. K. et al. 2003 Serial analysis of the plasma concentration of SARS coronavirus RNA in pediatric patients with severe acute respiratory syndrome. Clin. Chem. 49, 2085-2088. (doi:10.1373/clinchem.2003. 024588)
61. Peiris, J. S. et al. 2003a Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361, 1767-1772. (doi:10.1016/S0140- 6736(03)13412-5)
62. Peiris, J. S. et al. 2003b Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361, 1319-1325. (doi:10.1016/S0140-6736(03)13077-2)
63. Peiris, J. S., Yuen, K. Y., Osterhaus, A. D. & Stohr, K. 2003c The severe acute respiratory syndrome. N. Engl. J. Med. 349, 2431-2441. (doi:10.1056/NEJMra032498)
64. Peiris, J. S., Guan, Y. & Yuen, K. Y. 2004 Severe acute respiratory syndrome. Nat. Med. 10, S88-S97. (doi:10. 1038/nm1143)
65. Peng, G. W. et al. 2003 Epidemiological study on severe acute respiratory syndrome in Guangdong province. Zhonghua Liu Xing Bing Xue Za Zhi 24, 350-352.
66. Poon, L. L., Wong, O. K., Chan, K. H., Luk, W., Yuen, K. Y., Peiris, J. S. & Guan, Y. 2003 Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS). Clin. Chem. 49, 953-955. (doi:10. 1373/49.6.953)
67. Poon, L. L., Guan, Y., Nicholls, J. M., Yuen, K. Y. & Peiris, J. S. 2004 The aetiology, origins, and diagnosis of severe acute respiratory syndrome. Lancet Infect. Dis. 4, 663-671. (doi:10.1016/S1473-3099(04)01172- 7)
68. Poutanen, S. M. & Low, D. E. 2004 Severe acute respiratory syndrome: an update. Curr. Opin. Infect. Dis. 17, 287-294. (doi:10.1097/01.qco.0000136924.45049.7e)
69. Poutanen, S. M. & McGeer, A. J. 2004 Transmission and Control of SARS. Curr. Infect. Dis. Rep. 6, 220-227.
70. Poutanen, S. M. et al. 2003 Identification of severe acute respiratory syndrome in Canada. N. Engl. J. Med. 348, 1995-2005. (doi:10.1056/NEJMoa030634)
71. Qin, E. D. E. A. 2003 A complete sequence and comparative analysis of a SARS-associated virus (isolate BJ01). Chin. Sci. Bull. 48, 941-948. (doi:10.1360/03wc0186)
72. Qin, E. et al. 2003a A genome sequence of novel SARS-CoV isolates: the genotype, GD-Ins29, leads to a hypothesis of viral transmission in South China. Genomics Proteomics Bioinformatics 1, 101-107.
73. Qin, P.-Z., Zhou, R.-H., Liu, W.-S., Cai, W.-F., Li, Z.-R., Liu, Y.-F. & Wang, M. 2003b Establishment and evaluation on emergency surveillance and notification system of SARS in Guangzhou. Chin. J. Public Health 19, T3-T4.
74. Qu, X. X. et al. 2005 Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy. J. Biol. Chem. 280, 29 588-29 595. (doi:10.1074/jbc.M500662200)
75. Rainer, T. H. 2004 Severe acute respiratory syndrome: clinical features, diagnosis, and management. Curr. Opin. Pulm. Med. 10, 159-165. (doi:10.1097/00063198-20040 5000-00003)
76. Ren, W. et al. 2006 Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis. J. Gen. Virol. 87, 3355-3359. (doi:10. 1099/vir.0.82220-0)
77. Reynes, J. M. et al. 2005 Nipah virus in Lyle's flying foxes, Cambodia. Emerg. Infect. Dis. 11, 1042-1047.
78. Riley, S. et al. 2003 Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science 300, 1961-1966. (doi:10.1126/ science.1086478)
79. Rota, P. A. et al. 2003 Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300, 1394-1399. (doi:10.1126/science.1085952)
80. Rowe, T. et al. 2004 Macaque model for severe acute respiratory syndrome. J. Virol. 78, 11401-11404. (doi:10.1128/JVI.78.20.11401- 11404.2004)
81. Ruan, Y. J. et al. 2003 Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 361, 1779-1785. (doi:10.1016/S0140-6736(03)13414-9)
82. Sainz Jr, B., Rausch, J. M., Gallaher, W. R., Garry, R. F. & Wimley, W. C. 2005 Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein. J. Virol. 79, 7195-7206. (doi:10.1128/JVI.79.11.7195-7206.2005)
83. Seto, W. H., Tsang, D., Yung, R. W., Ching, T. Y., Ng, T. K., Ho, M., Ho, L. M. & Peiris, J. S. 2003 Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 361, 1519-1520. (doi:10. 1016/S0140-6736(03)13168-6)
84. Simmons, G., Reeves, J. D., Rennekamp, A. J., Amberg, S. M., Piefer, A. J. & Bates, P. 2004 Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc. Natl Acad. Sci. USA 101, 4240-4245. (doi:10. 1073/pnas.0306446101)
85. Song, H. D. et al. 2005 Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc. Natl Acad. Sci. USA 102, 2430-2435. (doi:10.1073/pnas.0409608102)
86. Stadler, K., Masignani, V., Eickmann, M., Becker, S., Abrignani, S., Klenk, H. D. & Rappuoli, R. 2003 SARS - beginning to understand a new virus. Nat. Rev. Microbiol. 1, 209-218. (doi:10.1038/nrmicro775)
87. Subbarao, K. et al. 2004 Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J. Virol. 78, 3572-3577. (doi:10.1128/JVI.78.7. 3572-3577.2004)
88. Tripet, B., Howard, M. W., Jobling, M., Holmes, R. K., Holmes, K. V. & Hodges, R. S. 2004 Structural characterization of the SARS-coronavirus spike S fusion protein core. J. Biol. Chem. 279, 20 836-20 849. (doi:10. 1074/jbc.M400759200)
89. Tsang, K. W. et al. 2003 A cluster of cases of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348, 1977-1985. (doi:10.1056/NEJMoa030666)
90. Tsui, S. K., Chim, S. S. & Lo, Y. M. 2003 Coronavirus genomic-sequence variations and the epidemiology of the severe acute respiratory syndrome. N. Engl. J. Med. 349, 187-188. (doi:10.1056/ NEJM200307103490216)
91. Tu, C. et al. 2004 Antibodies to SARS coronavirus in civets. Emerg. Infect. Dis. 10, 2244-2248.
92. Wang, L. F. & Eaton, B. T. 2001 Emerging paramyxoviruses. Infect. Dis. Rev. 3, 52.
93. Wang, H., Ding, Y., Li, X., Yang, L., Zhang, W. & Kang, W. 2003a Fatal aspergillosis in a patient with SARS who was treated with corticosteroids. N. Engl. J. Med. 349, 507-508. (doi:10.1056/NEJM200307313490519)
94. Wang, M. et al. 2003b Study on the epidemiology and measures for control on severe acute respiratory syndrome in Guangzhou city. Zhonghua Liu Xing Bing Xue Za Zhi 24, 353-357.
95. Wang, P. et al. 2004 Expression cloning of functional receptor used by SARS coronavirus. Biochem. Biophys. Res. Commun. 315, 439-444. (doi:10.1016/j.bbrc.2004.01.076)
96. Weinstein, R. A. 2004 Planning for epidemics: the lessons of SARS. N. Engl. J. Med. 350, 2332-2334. (doi:10.1056/ NEJMp048082)
97. Wentworth, D. E., Gillim-Ross, L., Espina, N. & Bernard, K. A. 2004 Mice susceptible to SARS coronavirus. Emerg. Infect. Dis. 10, 1293-1296.
98. Wong, R. S. et al. 2003 Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. Br. Med. J. 326, 1358-1362. (doi:10.1136/bmj.326.7403.1358)
99. Wong, S. K., Li, W., Moore, M. J., Choe, H. & Farzan, M. 2004a A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J. Biol. Chem. 279, 3197-3201. (doi:10.1074/ jbc.C300520200)
100. Wong, T. W. et al. 2004b Cluster of SARS among medical students exposed to single patient, Hong Kong. Emerg. Infect. Dis. 10, 269-276.
101. Wu, D. et al. 2005 Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates. J. Virol. 79, 2620-2625. (doi:10.1128/JVI.79.4.2620- 2625.2005)
102. Xu, R. H. et al. 2004a Epidemiologic clues to SARS origin in China. Emerg. Infect. Dis. 10, 1030-1037.
103. Xu, Y., Lou, Z., Liu, Y., Pang, H., Tien, P., Gao, G. F. & Rao, Z. 2004b Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core. J. Biol. Chem. 279, 49 414-49 419. (doi:10.1074/jbc. M408782200)
104. Xu, Y et al. 2004c Characterization of the heptad repeat regions, HR1 and HR2, and design of a fusion core structure model of the spike protein from severe acute respiratory syndrome (SARS) coronavirus. Biochemistry 43, 14 064-14 071. (doi:10.1021/bi049101q)
105. Yang, Z. Y., Huang, Y., Ganesh, L., Leung, K., Kong, W. P., Schwartz, O., Subbarao, K. & Nabel, G. J. 2004 pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J. Virol. 78, 5642-5650. (doi:10.1128/JVI.78.11.5642-5650.2004)
106. Yi, J.-R., Lin, L.-F., Duan, J.-H., Wu, J., Pei, F.-Q., Lu, W.-C., Cai, S.-W., Zheng, W.-Y. & Ying, W.-X. 2004 Analysis on murine-like animals carrying SARS coronavirus in the hygienic units related to SARS. Clin. J. Vector Biol. Control 15, 7-9.
107. Yu, D., Li, H., Xu, R. H., He, J. F. & Al, E. 2003 Prevalence of IgG antibody to SARS-associated coronavirus in animal traders-Guangdong Province, China. MMWR Morb. Mortal. Wkly Rep. 52, 986-987.
108. Zhong, N. S. & Zeng, G. Q. 2003 Our strategies for fighting severe acute respiratory syndrome (SARS). Am. J. Respir. Crit. Care Med. 168, 7-9. (doi:10.1164/rccm.200305-707OE)
109. Zhong, N. S. et al. 2003 Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet 362, 1353-1358. (doi:10.1016/S0140-6736(03) 14630-2)
110. Zhou, D.-H., Liu, Y.-F., Qin, P.-Z., Wang, M. & Du, L. 2003 Field study and epidemic report on the infectious atypical pneumonia of Guangzhou City. Chin. J. Epidemiol. 24, 360-361.